TRPS1 drives heterochromatic origin refiring and cancer genome evolution

Summary: Exploitation of naturally occurring genetic mutations could empower the discovery of novel aspects of established cancer genes. We report here that TRPS1, a gene linked to the tricho-rhino-phalangeal syndrome (TRPS) and recently identified as a potential breast cancer driver, promotes breas...

Full description

Bibliographic Details
Main Authors: Jianguo Yang, Xiaoping Liu, Yunchao Huang, Lin He, Wenting Zhang, Jie Ren, Yue Wang, Jiajing Wu, Xiaodi Wu, Lin Shan, Xiaohan Yang, Luyang Sun, Jing Liang, Yu Zhang, Yongfeng Shang
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Cell Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124721001285
id doaj-b658d630f0974c88869c1af9df9bf455
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jianguo Yang
Xiaoping Liu
Yunchao Huang
Lin He
Wenting Zhang
Jie Ren
Yue Wang
Jiajing Wu
Xiaodi Wu
Lin Shan
Xiaohan Yang
Luyang Sun
Jing Liang
Yu Zhang
Yongfeng Shang
spellingShingle Jianguo Yang
Xiaoping Liu
Yunchao Huang
Lin He
Wenting Zhang
Jie Ren
Yue Wang
Jiajing Wu
Xiaodi Wu
Lin Shan
Xiaohan Yang
Luyang Sun
Jing Liang
Yu Zhang
Yongfeng Shang
TRPS1 drives heterochromatic origin refiring and cancer genome evolution
Cell Reports
heterochromatic origin refiring
TRPS1
H3K9me3
breast cancer
cancer genome evolution
therapeutic resistance
author_facet Jianguo Yang
Xiaoping Liu
Yunchao Huang
Lin He
Wenting Zhang
Jie Ren
Yue Wang
Jiajing Wu
Xiaodi Wu
Lin Shan
Xiaohan Yang
Luyang Sun
Jing Liang
Yu Zhang
Yongfeng Shang
author_sort Jianguo Yang
title TRPS1 drives heterochromatic origin refiring and cancer genome evolution
title_short TRPS1 drives heterochromatic origin refiring and cancer genome evolution
title_full TRPS1 drives heterochromatic origin refiring and cancer genome evolution
title_fullStr TRPS1 drives heterochromatic origin refiring and cancer genome evolution
title_full_unstemmed TRPS1 drives heterochromatic origin refiring and cancer genome evolution
title_sort trps1 drives heterochromatic origin refiring and cancer genome evolution
publisher Elsevier
series Cell Reports
issn 2211-1247
publishDate 2021-03-01
description Summary: Exploitation of naturally occurring genetic mutations could empower the discovery of novel aspects of established cancer genes. We report here that TRPS1, a gene linked to the tricho-rhino-phalangeal syndrome (TRPS) and recently identified as a potential breast cancer driver, promotes breast carcinogenesis through regulating replication. Epigenomic decomposition of TRPS1 landscape reveals nearly half of H3K9me3-marked heterochromatic origins are occupied by TRPS1, where it encourages the chromatin loading of APC/C, resulting in uncontrolled origin refiring. TRPS1 binds to the genome through its atypical H3K9me3 reading via GATA and IKAROS domains, while TRPS-related mutations affect its chromatin binding, replication boosting, and tumorigenicity. Concordantly, overexpression of wild-type but not TRPS-associated mutants of TRPS1 is sufficient to drive cancer genome amplifications, which experience an extrachromosomal route and dynamically evolve to confer therapeutic resistance. Together, these results uncover a critical function of TRPS1 in driving heterochromatin origin firing and breast cancer genome evolution.
topic heterochromatic origin refiring
TRPS1
H3K9me3
breast cancer
cancer genome evolution
therapeutic resistance
url http://www.sciencedirect.com/science/article/pii/S2211124721001285
work_keys_str_mv AT jianguoyang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
AT xiaopingliu trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
AT yunchaohuang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
AT linhe trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
AT wentingzhang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
AT jieren trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
AT yuewang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
AT jiajingwu trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
AT xiaodiwu trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
AT linshan trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
AT xiaohanyang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
AT luyangsun trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
AT jingliang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
AT yuzhang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
AT yongfengshang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution
_version_ 1724226059314921472
spelling doaj-b658d630f0974c88869c1af9df9bf4552021-03-11T04:24:37ZengElsevierCell Reports2211-12472021-03-013410108814TRPS1 drives heterochromatic origin refiring and cancer genome evolutionJianguo Yang0Xiaoping Liu1Yunchao Huang2Lin He3Wenting Zhang4Jie Ren5Yue Wang6Jiajing Wu7Xiaodi Wu8Lin Shan9Xiaohan Yang10Luyang Sun11Jing Liang12Yu Zhang13Yongfeng Shang14Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Medicine, Hangzhou Normal University, Hangzhou 311121, China; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China; Corresponding authorDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China; Department of Biochemistry and Molecular Biology, School of Medicine, Hangzhou Normal University, Hangzhou 311121, China; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China; Corresponding authorSummary: Exploitation of naturally occurring genetic mutations could empower the discovery of novel aspects of established cancer genes. We report here that TRPS1, a gene linked to the tricho-rhino-phalangeal syndrome (TRPS) and recently identified as a potential breast cancer driver, promotes breast carcinogenesis through regulating replication. Epigenomic decomposition of TRPS1 landscape reveals nearly half of H3K9me3-marked heterochromatic origins are occupied by TRPS1, where it encourages the chromatin loading of APC/C, resulting in uncontrolled origin refiring. TRPS1 binds to the genome through its atypical H3K9me3 reading via GATA and IKAROS domains, while TRPS-related mutations affect its chromatin binding, replication boosting, and tumorigenicity. Concordantly, overexpression of wild-type but not TRPS-associated mutants of TRPS1 is sufficient to drive cancer genome amplifications, which experience an extrachromosomal route and dynamically evolve to confer therapeutic resistance. Together, these results uncover a critical function of TRPS1 in driving heterochromatin origin firing and breast cancer genome evolution.http://www.sciencedirect.com/science/article/pii/S2211124721001285heterochromatic origin refiringTRPS1H3K9me3breast cancercancer genome evolutiontherapeutic resistance